Back to Agenda
Session 8: Digital Health in Clinical Development
Session Chair(s)
Venkat Sethuraman, PHD, MBA, MS
Senior Vice President, Global Biometrics and Data Sciences, Bristol Myers Squibb, United States
Andrew Potter, PHD
Associate Director, Biostatics, United States
With the advancement of digital health technologies, cloud computing power, and big data analytics, there is an opportunity to develop an integrated strategy to optimize clinical trial designs and advance the development of innovative medicines. In this session, we will learn from the industry and FDA speakers how digital technologies are leveraged to support clinical development.
Learning Objective : - Describe how digital endpoints captured through digital sensors are used in clinical trials
- Discuss how algorithms are developed to detect, diagnose, and monitor; and how they are deployed into clinical practice
- Recognize the current regulatory landscapes with respect to digital health technologies
- Discuss how pharma is leveraging digital technologies in clinical research
Speaker(s)
Alex Morozov, MD, PHD
Vice President, Head of Digital Health - Global Drug Development, Bristol Myers Squibb , United States
Digital Health from Clinical Trials to Clinical Practice
Sandeep Menon, PHD
Chief Scientific Officer of Artificial Intelligence and Digital Science and SVP,, Pfizer Inc, United States
Application of Digital Medicine in Drug Development
Christina Webber
General Engineer, FDA, United States
Remote Data Acquisition in Clinical Investigations Using Digital Health Technologies
Have an account?